skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

29 Total results for product and free and sample content found

Pink Sheet

US Drug Pricing Reform Post-Election: Scenarios To Consider And Lessons Learned

US Election Drug Pricing Reform

Regardless of the outcomes of the US elections, drug pricing is likely to take a back seat to COVID as policy focus. But the pandemic does offer pharma an opportunity for partnerships with payers on health outcomes. Commonwealth Fund’s Liz Fowler, South Capitol’s John O’Brien and ICER’s Steve Pearson discuss where drug pricing stands in public opinion, whether policies embraced by President Trump will have staying power, and the conditions needed in the policy environment for major change.

Topic US Election 2020 Policy & Regulation Drug Pricing

Medtech Insight

US Election 2020: Industry Loses Three Favored Incumbents In Battle For Senate Control

US Election senate battle

A few of the US Senate candidates favored and given tens of thousands of dollars by industry have lost their battles for re-election

Topic US Election 2020 Legislation

Pink Sheet

Biden Administration May Push Rx Pricing To Back Burner With Senate That Stays Pharma Friendly

Biden Administration Rx Pricing

A Biden Administration with near-term priorities other than drug pricing and a Republican-controlled Senate dedicated to blocking any legislation that would enact government price controls is a relatively positive outcome for industry

Topic US Election 2020 Drug Pricing

Pink Sheet

China-US Relationship Hinges On Changing Internal, External Forces

US Election China Relations

Given the ongoing election challenges in the US, China has yet to officially congratulate Joe Biden as the next US president, although many world leaders are already hailing a reset in US foreign policy. Many are wondering if this and other moves indicate a quiet internal shift for China's high tech and life sciences sectors, just days after Beijing concluded a high-level plenary meeting outlining its priorities for the next five years.

Topic US Election 2020 China

Medtech Insight

US Election 2020: Almost All House Members Backed By Industry PAC Dollars Retain Seats

US Election 2020 PAC dollars

Out of 31 US House incumbents supported by high amounts of medtech industry political action committee (PAC) dollars, only one – Chrissy Houlahan of Pennsylvania – lost in last week’s election.

Topic US Election 2020 Policy & Regulation Legislation

Pink Sheet

Biden's COVID-19 Advisory Board Bodes Well For Science-Driven FDA

Biden Kamala Covid19 advisory board

Two prominent former US FDA officials are a part of the president-elect’s new COVID-19 advisory board. Biden’s emphasis on scientific independence, including a commitment to publicly release vaccine trial data, could help restore public confidence in the agency and coming COVID-19 vaccines.

Topic US Election 2020 Coronavirus FDA

Pink Sheet

Biden, Germany And Bringing A National Drug Pricing Negotiation Process To US

Biden US Election 2020 final debate

Germany uses government facilitated price negotiations between publicly funded insurers and manufacturers that are based on an independent assessment of how much added value a drug provides.

Topic US Election 2020 Drug Pricing

Pink Sheet

Divided FTC Okays Mylan-Upjohn Merger But Election Outcome Could Impede Future Deals

mylan pfizer upjohn merger

Commissioners vote 3-2 that Mylan and Pfizer’s Upjohn can combine after divesting seven products; dissenting votes focus on price fixing allegations as commissioners Chopra and Slaughter criticize majority for not addressing government’s case against Pfizer and Mylan. Former FTC attorneys note that if Biden wins the presidential election, he could nominate one of the dissenters to FTC chair and give more traction to their views.

Topic US Election 2020 M A Legal Issues

Medtech Insight

US Election 2020: Here's Who Industry's Donating To

US Election 2020 Medtech Insight

US senatorial friends of the device industry running competitive races in 2020 are being aided by medtech PAC dollars this fall

Topic US Election 2020 Policy & Regulation Medtech

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: